相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
Joseph Cursons et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function
Clara Degos et al.
FRONTIERS IN IMMUNOLOGY (2019)
Therapeutic blockade of activin-A improves NK cell function and antitumor immunity
Jai Rautela et al.
SCIENCE SIGNALING (2019)
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
Fernando Souza-Fonseca-Guimaraes et al.
TRENDS IN IMMUNOLOGY (2019)
Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell
Chu Lin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
Jingjing Cong et al.
CELL METABOLISM (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer
Antonino Bruno et al.
FASEB JOURNAL (2018)
Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity
Marco Colonna
IMMUNITY (2018)
Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer
Takeshi Ishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization
Annalisa Bosi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Innate Lymphoid Cells: 10 Years On
Eric Vivier et al.
CELL (2018)
Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
Diana Cadena Castaneda et al.
FRONTIERS IN IMMUNOLOGY (2018)
Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials
Wade Chun-Wai Suen et al.
CANCER INVESTIGATION (2018)
Liver-infiltrating CD11b(-)CD27(-) NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
Qiong-Fang Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
M. Ilander et al.
LEUKEMIA (2017)
High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
Cheng Sun et al.
ONCOIMMUNOLOGY (2017)
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Delphine Rea et al.
HAEMATOLOGICA (2017)
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency
Yannick Simoni et al.
IMMUNITY (2017)
The Broad Spectrum of Human Natural Killer Cell Diversity
Aharon G. Freud et al.
IMMUNITY (2017)
Engineering Natural Killer Cells for Cancer Immunotherapy
Katayoun Rezvani et al.
MOLECULAR THERAPY (2017)
A distinct innate lymphoid cell population regulates tumor-associated T cells
Sarah Q. Crome et al.
NATURE MEDICINE (2017)
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Delphine Rea et al.
HAEMATOLOGICA (2017)
Generation of Off-the-Shelf Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
Jieming Zeng et al.
STEM CELL REPORTS (2017)
In Vitro culture with interleukin-15 leads to expression of activating receptors and recovery of natural Killer cell Function in acute Myeloid Leukemia Patients
Beatriz Sanchez-Correa et al.
FRONTIERS IN IMMUNOLOGY (2017)
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Phase 1 clinical trial of adoptive immunotherapy using off-the-shelf activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia
Michael Boyiadzis et al.
CYTOTHERAPY (2017)
ILC1 Confer Early Host Protection at Initial Sites of Viral Infection
Orr-El Weizman et al.
CELL (2017)
SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling
Victor S. Cortez et al.
NATURE IMMUNOLOGY (2017)
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao et al.
NATURE IMMUNOLOGY (2017)
The breast tumor microenvironment alters the phenotype and function of natural killer cells
Tamara Krneta et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
Saida Dadi et al.
CELL (2016)
Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance
Timothy E. O'Sullivan et al.
IMMUNITY (2016)
Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands
Victor S. Cortez et al.
IMMUNITY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Targeting natural killer cells in cancer immunotherapy
Camille Guillerey et al.
NATURE IMMUNOLOGY (2016)
Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients
Nayeli Goreti Nieto-Velazquez et al.
TRANSLATIONAL ONCOLOGY (2016)
The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia
Fengyan Jin et al.
ONCOTARGET (2016)
Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
Yaewon Yang et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Human Circulating and Tissue-Resident CD56bright Natural Killer Cell Populations
Janine E. Melsen et al.
FRONTIERS IN IMMUNOLOGY (2016)
Emerging insights into natural killer cells in human peripheral tissues
Niklas K. Bjorkstrom et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
Naoyuki Sakamoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets
Michelle L. Robinette et al.
NATURE IMMUNOLOGY (2015)
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Richard W. Childs et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs
Georg Gasteiger et al.
SCIENCE (2015)
Characterization of tumor infiltrating Natural Killer cell subset
Inbar Levi et al.
ONCOTARGET (2015)
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
Christine Pasero et al.
ONCOTARGET (2015)
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
Katayoun Rezvani et al.
FRONTIERS IN IMMUNOLOGY (2015)
Utilizing chimeric antigen receptors to direct natural killer cell activity
David L. Hermanson et al.
FRONTIERS IN IMMUNOLOGY (2015)
Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial
Jun Imagawa et al.
LANCET HAEMATOLOGY (2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
Kurt Schönfeld et al.
MOLECULAR THERAPY (2014)
Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell Lineages
Christoph S. N. Klose et al.
CELL (2014)
T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
Man Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow
Cecile Daussy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
Paolo Carrega et al.
JOURNAL OF IMMUNOLOGY (2014)
A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis
Antonino Bruno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
A committed precursor to innate lymphoid cells
Michael G. Constantinides et al.
NATURE (2014)
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
Dorothy K. Sojka et al.
ELIFE (2014)
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Ines Pires da Silva et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Cancer-inducecd alterations of NK-mediated target recognition: current and investigational pharmacological strategies aiming at restoring NK-mediated anti-tumor activity
Anne-Sophie Chretien et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
Young-Jun Park et al.
CANCER RESEARCH (2013)
Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells
S. Liu et al.
CELL DEATH AND DIFFERENTIATION (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR
Noa Stanietsky et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Intraepithelial Type 1 Innate Lymphoid Cells Are a Unique Subset of IL-12-and IL-15-Responsive IFN-γ-Producing Cells
Anja Fuchs et al.
IMMUNITY (2013)
Peripheral Blood NK Cells from Breast Cancer Patients Are Tumor-Induced Composite Subsets
Emilie Mamessier et al.
JOURNAL OF IMMUNOLOGY (2013)
Conversion of Peripheral Blood NK Cells to a Decidual NK-like Phenotype by a Cocktail of Defined Factors
Ana Sofia Cerdeira et al.
JOURNAL OF IMMUNOLOGY (2013)
Human type 1 innate lymphoid cells accumulate in inflamed mucosa! tissues
Jochem H. Bernink et al.
NATURE IMMUNOLOGY (2013)
Lung tumor microenvironment induces specific gene expression signature in intratumoral NK cells
Melanie Gillard-Bocquet et al.
FRONTIERS IN IMMUNOLOGY (2013)
The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
Antonino Bruno et al.
NEOPLASIA (2013)
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol
Ulrike Koehl et al.
FRONTIERS IN ONCOLOGY (2013)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturation
Scott M. Gordon et al.
IMMUNITY (2012)
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
Antonio Curti et al.
BLOOD (2011)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova et al.
CANCER RESEARCH (2011)
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller et al.
CYTOTHERAPY (2011)
CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells
Binqing Fu et al.
IMMUNOLOGY (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells
Paola Vacca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
Janelle A. Olson et al.
BLOOD (2010)
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
Miroslaw J. Szczepanski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
Eleni G. Iliopoulou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
Jeffrey E. Rubnitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Maturation of mouse NK cells is a 4-stage developmental program
Laura Chiossone et al.
BLOOD (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Regulatory Natural Killer Cells: New Players in the IL-10 Anti-Inflammatory Response
Eric Vivier et al.
CELL HOST & MICROBE (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Mirna Balsamo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy
Claudia Carlino et al.
BLOOD (2008)
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56BrightCD16- cells and display an impaired capability to kill tumor cells
Paolo Carrega et al.
CANCER (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Accelerated tumor growth in mice deficient in DNAM-1 receptor
Akiko Iguchi-Manaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
Alessandra Beano et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Tumor Growth Decreases NK and B Cells as well as Common Lymphoid Progenitor
John Richards et al.
PLOS ONE (2008)
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Grazia Maria Spaggiari et al.
BLOOD (2008)
Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients
Gordana Konjevic et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
TGFβ promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells
Derin B. Keskin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
Cyril Fauriat et al.
BLOOD (2007)
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
Jacob Hanna et al.
NATURE MEDICINE (2006)
Tumor growth impedes natural-killer-cell maturation in the bone marrow
John O. Richards et al.
BLOOD (2006)
CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity
Y Hayakawa et al.
JOURNAL OF IMMUNOLOGY (2006)
NKp46 and NKG2D receptor expression in NK cells with CD56(dim) and CD56(bright) phenotype: regulation by histamine and reactive oxygen species
AI Romero et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Natural-killer cells and dendritic cells: l' union fait la force
T Walzer et al.
BLOOD (2005)
Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients
C Fauriat et al.
BLOOD (2005)
NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor
M Vitale et al.
BLOOD (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
RT Costello et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
FR Villegas et al.
LUNG CANCER (2002)
The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma
I Takanami et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
分享论文
